ZURA
Zura Bio Ltd
Key Financials
Operating Income
$-75246000
↓ 36.3%
Net Income
$-68650000
↓ 31.0%
Total Assets
$113.9M
↓ 36.5%
Cash & Equivalents
$109.4M
↓ 38.0%
EPS (Diluted)
$-1.06
↓ 76.7%
Shareholders' Equity
$101.5M
↓ 30.8%
Total Liabilities
$12.4M
↓ 36.4%
Operating Cash Flow
$-64815000.00
↓ 130.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/12/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| SCHEDULE 13G/A | 5/6/2026 | View on SEC |
| ARS | 4/30/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| 8-K | 4/23/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ZURA |
| Company Name | Zura Bio Ltd |
| CIK | 1855644 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | 858-247-0520 |